Live Analyst Rating Changes 28648 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Andrew Simms
BER

Andrew Simms

Berenberg Bank
Wall Street Analyst
★★★☆☆
#979
on 13Foresight · ranked by our own returns
67%
Success Rate
+9.2%
Average Return
12 of 18 calls profitable · -2.8% vs benchmark
S&P 500 (SPY)
📈 Across the calls we could measure, roughly 67% of Andrew Simms's ratings turned a profit when each position was held for 1 year — averaging +9.2% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

11 Buy 6 Hold 0 Sell
Andrew's Stock Coverage 17 ratings · 2026-08-30
Company Date Position Consensus ⓘ Price Target ⓘ 1-Yr Return vs S&P 500 ⓘ
SE:EPI.A
Epiroc AB
 Aug 27, 2026 HOLD Hold
-16.7% avg upside
16 analysts
 — · ·
SE:SAND
Sandvik AB
 Aug 27, 2026 HOLD Hold
-20.8% avg upside
16 analysts
$415.00
5.48% Upside
 · ·
GB:ABDP
AB Dynamics
 Jul 29, 2026 BUY Strong Buy
+154.9% avg upside
3 analysts
$1700.00
99.21% Upside
 +14.5% ·
GB:ROR
Rotork plc
 Jul 17, 2026 HOLD Buy
+217.0% avg upside
17 analysts
$503.00
3.81% Upside
 +0.1% ·
GB:HLMA
Halma plc
 Jul 15, 2026 BUY Buy
+127.7% avg upside
20 analysts
$4200.00
15.73% Upside
 -0.1% ·
GB:VLX
Volex plc
 Jul 14, 2026 BUY Strong Buy
-11.7% avg upside
5 analysts
$700.00
12.19% Upside
 +19.7% ·
GB:TTG
TT Electronics
 Apr 10, 2026 BUY Buy
+20.1% avg upside
9 analysts
$150.00
10.22% Upside
 +12.5% ·
GB:JDG
Judges Scientific
 Mar 31, 2026 BUY Buy
+19.5% avg upside
2 analysts
$5600.00
39.15% Upside
 -6.7% ·
GB:VSVS
Vesuvius
 Mar 13, 2026 BUY Buy
+25.2% avg upside
8 analysts
$520.00
33.79% Upside
 -7.8% ·
GB:RHIM
RHI Magnesita NV
 Jul 31, 2025 BUY Buy
+3015.1% avg upside
7 analysts
$4000.00
45.14% Upside
 +25.6% ·
GB:VID
Videndum plc
 May 16, 2025 HOLD Buy
+3.0% avg upside
2 analysts
$80.00
67.35% Downside
 · ·
GB:SPX
Spirax Group
 May 15, 2025 HOLD Buy
+23.1% avg upside
15 analysts
$7000.00
1.53% Downside
 +13.5% ·
GB:SMIN
Smiths Group plc
 Mar 26, 2025 HOLD Buy
+731.1% avg upside
16 analysts
$1850.00
29.24% Downside
 +16.9% ·
GB:BOY
Bodycote
 Mar 25, 2025 BUY Buy
+430.2% avg upside
12 analysts
$800.00
12.32% Downside
 +12.3% ·
GB:IMI
IMI plc
 Mar 04, 2025 BUY Buy
+180.4% avg upside
23 analysts
$2300.00
26.19% Downside
 +42.3% ·
GB:MACF
Macfarlane
 Jan 21, 2025 BUY Strong Buy
+85.0% avg upside
2 analysts
$135.00
75.33% Upside
 -33.3% ·
SMGZY
Smiths Group
 Oct 21, 2015 BUY Strong Buy
-50.3% avg upside
2 analysts
 — +22.6% ·
🔒 12 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Andrew Simms — Frequently Asked Questions
How accurate are Andrew Simms's stock ratings?
Based on the calls 13Foresight could measure, about 67% of Andrew's ratings were profitable over a one-year hold, with an average return of +9.2% per rating, or -2.8% versus the S&P 500. We score every analyst the same way, from historical prices. Each return is measured in the stock's own trading currency, so for non-US listings the S&P 500 comparison leaves out currency moves.
How is Andrew ranked on 13Foresight?
Andrew Simms is currently ranked #979 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Andrew cover?
Andrew most recently has ratings on SE:EPI.A, SE:SAND, GB:ABDP, GB:ROR, GB:HLMA, GB:VLX, GB:TTG, GB:JDG, GB:VSVS, GB:RHIM, GB:VID, GB:SPX and 5 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.